News and Views

The TSRI team is now actively seeking a pharmaceutical company partner or other funding to sponsor clinical trials.

“This deal is the latest example of our corporate partnership strategy,” says Scott Forrest, TSRI’s vice president for business development.

The findings from the MacRae lab open the door to a new class of therapies.

Work from the Wu lab shows a little-understood mechanism, although error-prone, has an overall protective role.

Team Finds Dissimilar Proteins Evolved Similar 7-Part Shape
Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
Scientists Help Unravel a Central Mystery of Alzheimer’s Disease
Team Finds Interferon, One of the Body’s Own Proteins, Induces Persistent Viral Infection
New Vaccine-Design Approach Targets HIV and Other Fast-Mutating Viruses
Scientists Identify First Potentially Effective Therapy for Human Prion Disease
Study Reveals How Serotonin Receptors Can Shape Drug Effects from LSD to Migraine Medication
Philanthropist John Moores Gives $2 Million to TSRI to Develop River Blindness Field Test
Hugh Rosen Makes Strides Toward New Treatments for MS, Flu and PTSD
Scientists Find Surprising New Influence on Cancer Genes
Scientists Find Promising New Approach to Preventing Progression of Breast Cancer
Team Finds a Key Element of Lupus, Suggesting Better Drug Targets
Scientists Uncover Previously Unknown Mechanism of Memory Formation
Andrew Su Sets Out to Scale Mountains of Data